Microbot Medical (MBOT)
(Delayed Data from NSDQ)
$0.89 USD
-0.01 (-1.11%)
Updated Apr 18, 2024 04:00 PM ET
Pre-Market: $0.94 +0.05 (5.62%) 9:02 AM ET
2-Buy of 5 2
D Value B Growth A Momentum B VGM
Price, Consensus and EPS Surprise
MBOT 0.89 -0.01(-1.11%)
Will MBOT be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for MBOT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MBOT
Microbot Medical (MBOT) Files IDE to Start Human Clinical Study
Microbot Medical (MBOT) Announces Positive GLP Study Results
MBOT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Microbot Medical Inc. (MBOT) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Other News for MBOT
Analysts Are Bullish on Top Healthcare Stocks: Halozyme (HALO), Cognition Therapeutics (CGTX)
Microbot Medical Shares Status Following Recent Geopolitical Events
Microbot Medical operations remain on track amid Middle East tensions, shares up
Microbot says activities continue without interruption amid geopolitical events
3 AI Stocks Wall Street Expects to Return Up to 595% in 2024